Comparison of Effectiveness of Low Dose Laser and Transcutaneous Electrical Stimulation in Hemipl… (NCT07203222) | Clinical Trial Compass
RecruitingNot Applicable
Comparison of Effectiveness of Low Dose Laser and Transcutaneous Electrical Stimulation in Hemiplegic Shoulder
Turkey (Türkiye)45 participantsStarted 2025-09-24
Plain-language summary
The primary aim of this study is to compare the efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) and Low Level Laser Therapy (LLLT), which are analgesic modalities that play an important role in the treatment of this frequently encountered complication. The secondary aim of the study is to evaluate its effectiveness on upper extremity function, quality of life, sleep, and fatigue.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged 18-75 years
* Patients with shoulder pain on the hemiplegic side \*Mini mental state examination ≥ 25
* History of stroke within the last 2 weeks to 6 months
* Patients with shoulder pain scoring 40-100 points on the visual analogue scale (moderate to severe) will be included.
Exclusion Criteria:
* Patients who refuse to provide written consent or attend follow-up visits
* Being under 18 years of age
* Patients with motor aphasia
* Patients who have had a shoulder injection within the last 3 months
* Patients who have undergone upper extremity botulinum toxin application within the last 6 months
\*Pregnant women or those planning to become pregnant
* Inflammatory rheumatic disease
* Patients who have undergone shoulder injury and surgery prior to stroke
* Patients with other conditions that could explain shoulder pain
* Patients with complex regional pain syndrome
* Patients with a history of epilepsy, pacemaker, or arrhythmia diagnosis
* Malignancy
* Diseases such as Alzheimer's or dementia that cause cognitive impairment -History of psychiatric disorders such as major depression or personality disorders
* Alcohol and drug addiction
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Visual Analogue Scale (VAS)
Timeframe: patients will be checked on first day of hospitalization, after treatment at 4 weeks and after treatment 3 months